chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment medications were reported  No Adverse events were reported
Patient was here for a nurse visit to receive the HPV vaccine. Vaccine was administered and about 2 minutes later mom came out of the room yelling for help. When I entered the room the patient was passed out in her chair. I assured mom that this can happen with HPV vaccines. Patient waited for about 10 more minutes in the room while the clinical staff continued to check on her. Patient walked out of our office feeling well.
tennis ball size hard lump with itching at injection site, sore and hot to the touch 7 days after 1st vaccine.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. The patient's medical history was not reported. On 01-APR-2015, the patient was received improperly stored VARIVAX (lot # K005427, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
Systemic rash covering part of arms & torso; This is a spontaneous report from a contactable consumer (patient). A 70-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6701), via an unspecified route of administration, administered in the right arm on 10Feb2021 at 15:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included coronary heart disease (CHD), nocturia, hypertension, lumbago, cervicalgia and allergies to statins. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medication included evolocumab (REPATHA) 140mg twice a month and other unspecified medications. The patient experienced systemic rash covering part of arms & torso on 23Feb2021. No treatment was received for the systemic rash. The outcome of event systemic rash was recovering.
I started feeling very exhausted, sore throat, sinus pressure, and fever for the first day. I tested positive for COVID-19 at home. My doctor prescribed me Paxlovid. I started to feel better in a couple of days.
CDC Reports: 3 mo infant received DTP/OPV on 12DEC89 and died same day. Infant was put down for a nap approx 1PM. Mother checked on infant approx 4PM no response dead on arrival at hospital.
SERIOUS MIGRAINE TREATED AT E.R.-DURATION OF MIGRAINE 2 DAYS-CT SCAN PERFORMED; BREATHING DIFFICULTY-TREATED ON 09/22/13 @ IMMEDIATE CARE.
Mild nausea, strong  fatigue, very bad muscle and joint pain lasted about 3 to 4 days
This spontaneous report as received from an other health professional (registered nurse) that refers to 4 others patients who since July 2012 that had also experienced induration at the injection site after administration of LIQUID PEDVAXHIB. Additional information has been requested. This one of several reports received from the same source.
Started with an itchy rash that spread throughout the joints and buttocks and later throughout body.  My joints swelled up, became stiff and extremely painful and cannot do my ordinary normal routine.
Body aches; Chills; temperature was up to a 101; pains/she said she can't even move because it hurt; Fatigue; Felt horrible/felt very bad; This is a spontaneous report from a contactable Physician.  A female patient of an unspecified age received second dose of bnt162b2 (PFIZER- BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 11Jan2021 at single dose for COVID prevention. Medical history included breast cancer, rheumatoid arthritis. The patient's concomitant medications were not reported. The patient said that she felt horrible, she had body ache, pains and chills and that was just horrible. she felt very bad you know body aches and chills. She was a doctor, she wasn't even able to go to the work. She was not going to go to work tomorrow and her temperature was up to a 101 and she said she can't even move because it hurt when she move. Body aches, chills, fever, fatigue, she just said she just felt horrible. She did have some blood work done about three weeks ago from her oncologist. The outcome of events was unknown.  Information on the Batch/Lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021044872 Same reporter, same drug, different patient
Pt recvd 1st dose of Hep B vax on 5NOV90 & 24 hrs p/inject pt exp h/a; 48 hrs post vax exp myalgia 7 arthralgia; 72 hrs p/inject devel facial edema & a red rash on arms; pt was seen by MD & tx Pred & APAP; pt later recovered;
Patient was given a Pfizer 1st dose & Moderna 2nd dose 21 days later.
This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date), PRODUCT STORAGE ERROR (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date), PRODUCT STORAGE ERROR (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date), PRODUCT STORAGE ERROR (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and PRODUCT STORAGE ERROR (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    No concomitant medications were reported. No treatment medications were reported.
While I had nausea and fatigue Saturday morning after the vaccine, this report is about my nasty shingles outbreak. Rash started on left hand and calf and spread up my leg. Started with itching, not so much pain as in my prior outbreak which when I was 19 was local on my left arm. This is a bigger rash are, blistered red swollen, oozing, burning...the usual.
she had a pneumonia shot before and it hurt; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 71 year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) (Batch/Lot number: unknown) as dose number unknown, single for immunisation. Relevant medical history included: "heart patient " (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "she had a pneumonia shot before and it hurt".  No follow-up attempts are possible. No further information is expected.
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium
I thought I had allergies and then I had the fever, 100.9 degrees on Sunday afternoon. It felt like allergy symptoms at first. I was very stuffy and run down. I took a rapid test and it was positive. The next day I was feeling more run down than what allergies were. That same day I went to the ER on 6/7, they gave me the PAXLOVID prescription. Basically I was exhausted, absolutely no energy, coughing, my eyes were bothering me. The first half was more similar to allergies and then on the 17th is when I finally tested negative. The last three to four days of my symptoms I had to use my inhaler consistently and it lasted for the following 2 and a half weeks after that. I did have a lot of gastrointestinal issues during. I did lose my appetite and also had diarrhea.
I got my vaccine while being on my minstrel cycle. My period lasted for 4weeks and it was very heavy. I experienced blood clots the size of a silver dollar. I had serve headaches.
10 minutes after RIG vaccine, patient reported mild tremors and lightheadedness. 5 minutes later she had increased shaking and sensation; her throat was closing. Was given .3ccs epinephrine by means of EPIand nebulizer treatment. 911 called; patient was transported to ER.
5:15 PM Nausea, 5:45 PM Shaking, 6:00 PM Diarrhea, 6:45 PM Extreme Shaking, 7:15 PM Vomiting, 7:45 PM Retired to Bed With Heating Pad on Chest to Control Shaking, 12:30 AM Fever Broke with soaked Bed Clothes, 9:00 AM, 11/04/2014, Near Normal.
Symptoms from typhoid vaccine administered on 7 Jun 08: headache, body aches, fever, stiffness in neck, and chills.  Patient began experiencing symptoms within 2 hours.  Patient sought medical care that evening at ER.  Patient had several tests administered and was treated with Motrin.  No medication prescribed.  Symptoms from smallpox vaccine administered to her on 8 Jun 08: headache, body aches, stiffness in neck, chills, and sore throat.  Patient experienced these symptoms within 8-24 hours for a duration of approximately a week.  Patient sought medical care 24 hours after receiving the vaccine.  Treatment included a mouth wash that she used and swallowed and OTC ibuprofen following medication schedule recommended by manufacterer.  As of 23 Jun 2008, patient is experiencing little to no symptoms.
Tenderness in whole upper arm; localized reaction with redness, swollen deltoid and underarm; fever of 100 F starting on day of vaccination.
Client complained of leg cramps when walking long distance five days after receiving Rabies vaccine and Rabies IG.
Severe pain and decrease range of motion in left shoulder. Evaluated in the Emergency Dept on 10/4/18 and was told I had SIRVA (shoulder injury related to vaccine administration) referred to orthopedic MD. Seen by Dr. on 10/4/18. Received cortisone injection in left shoulder and was given script for MRI w/o contrast of left shoulder. Awaiting authorization. The pain is returning as on 10/17/2018 (perhaps cortisone injection is wearing off)? Still having difficulty pain when taking off shirts, bras, movement of left shoulder.
2 days after vaccination developed somnolence, fever, rash, constant moaning. Before vaccination using 20+ words fluently, since 2/16/17 he is non-verbal. He has been diagnosed with speech regression, developmental delay, encephalopathy, autism spectrum disorder.
4/11 11:30 vaccination  11:40 I felt had a head rush and my heart started pounding like it never had before. I reported back to the EMTs on site. They monitored me. After another 10 minutes, I was not feeling better, nauseous. My BP rose and I went into a fibrillation. They transported me at that time to the ER. The Afib went away on its own. It was probably an hour at the mobile clinic and ER ride; by the time I had arrived my afib had resolved on its own. Discharged Heart palpitations over the next few weeks. The following Sunday, I started to feel like I was going back into Afib. By the time I got there, everything was ok. They sent me home with a heart monitor for 48 hours. I will get the information on 5/7/2021. *5/7/2021 follow up appointment with PCM to find results of HR monitor.
Information has been received from a physician concerning her 8.5 year old daughter who on 24-JUL-2007 was vaccinated in the right arm with a dose of VARIVAX (Merck) (Lot number 657100/0454U). On 24-JUL-2007, the patient experienced a large, warm swollen area to the upper right arm. It is not known if the patient sought medical attention. As of the date of this report, the patient's outcome was unknown. Additional information was received from the patient's mother (the physician). The mother did not report the reaction to the physician who "ordered the shot - as a lab only visit now a year ago". This is one of two reports from the same source. No further information as expected.
Tested positive for COVID19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event since an unknown date.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced COVID-19 (Tested positive for COVID19). At the time of the report, COVID-19 (Tested positive for COVID19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment drugs were not provided,  Concomitant medicines were not included,  Action taken with mRNA-1273 in response to the event was unknown
Case previously recorded as MA2009-4545. Initial case report received from a nurse, on 18 NOV 2009. A patient 1-years-old male was accidentally vaccinated with FLUVIRIN 2009/2010 (batch no. 102126P1A) 0.5mL i.m on 17 NOV 2009. No adverse effect was reported. Reference no: NA09-008426.
On day 8 post vaccine, my arm started itching. Large red circular rash around injection site.
Numbness in both hands; Reports tingling under her neck, in the chin area and tingling in both her hands from time to time; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 37 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Sep2021 (Batch/Lot number: unknown) at the age of 37 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing), notes: Patient History: No. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 01, Anatomical location: Left Arm), administration date: Aug2021, when the patient was 37 years old, for COVID-19 immunization. The following information was reported: HYPOAESTHESIA (non-serious) with onset 11Sep2021, outcome "not recovered", described as "Numbness in both hands"; PARAESTHESIA (non-serious) with onset 11Sep2021, outcome "recovering", described as "Reports tingling under her neck, in the chin area and tingling in both her hands from time to time". Therapeutic measures were taken as a result of hypoaesthesia, paraesthesia.  Additional Information: No Investigation Assessment: No Additional Context: on Saturday she had tingling under the neck, on her chin area as well as both of her hands, she also would experience numbness in the hands, she wants to report this because she feels like it can get worse. Tingling Outcome: On Saturday it was too much, but is better now. Numbness Outcome: It is still the same. Treatment: On Saturday she took Advil. Allergies: None. Patient  has not made any visit to the Emergency room, and has not seen a doctor. She would like to know, is this a normal side effect, how long does it usually last for, does she need to see a doctor for this.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Severe body Rash; Dizziness; Lightheaded; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheaded), RASH (Severe body Rash) and DIZZINESS (Dizziness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced DIZZINESS (Lightheaded) and DIZZINESS (Dizziness). On 10-Mar-2021, the patient experienced RASH (Severe body Rash). At the time of the report, DIZZINESS (Lightheaded), RASH (Severe body Rash) and DIZZINESS (Dizziness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications included Allegra, Benadryl.   Reporter did not allow further contact
Pt received Pfizer x2.  Pt tested COVID + on 9/29/21 and admitted to hospital for COVID on 10/2/2021. Pt receiving remdesivir and dexamethasone. During admission, had ICH.
The following was reported by the vaccinated individual:  I received my first dose of Pfizer Covid vaccination in my right deltoid on Monday January 4, 2021. 30 minutes post injection I began experiencing numbness and tingling in my left cheek, left arm and hand, and left leg & foot. This continued on Jan 5th. On Jan. 6th the symptoms resolved.
Information has been received through a pregnancy registry from a 21 year old female with penicillin allergy who on 24-APR-2007 was vaccinated with a third dose 0.5 mL of GARDASIL. There was no concomitant medication. On 24-APR-2007 the patient experienced vaccine exposure during pregnancy. The patient's last menstrual period was 24-MAR-2007 and the estimated due date was 29-DEC-2007. A blood test was positive for pregnancy. Follow up information has been received from the nurse who reported that the patient had a spontaneous abortion during her pregnancy. The nurse could not confirm the estimated gestational age at the time of the "miscarriage". Upon internal review, the patient's spontaneous abortion was considered to be an other important medical event. This patient experienced another adverse event reported in WAES# 806USA002235. Additional information has been requested.
Acute on chronic diastolic congestive heart failure - ED visit and hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
For approx. 3 days post-vaccination, pt. experienced fever, nausea, vomiting, body aches. Site of vaccination became sore, swollen, red, and redness spread down arm (not past elbow). A hard nodule developed. Pt. states these are resolving.
Red Injection Site (2" Circumference); Itching Injection Site; Very Sore Injection Site; Swollen Injection Site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-May-2021 and was forwarded to Moderna on 10-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE ERYTHEMA (Red Injection Site (2" Circumference)), VACCINATION SITE PAIN (Very Sore Injection Site) and VACCINATION SITE SWELLING (Swollen Injection Site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced VACCINATION SITE PAIN (Very Sore Injection Site) and VACCINATION SITE SWELLING (Swollen Injection Site). On 04-May-2021, the patient experienced VACCINATION SITE PRURITUS (Itching Injection Site). On 10-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red Injection Site (2" Circumference)). On 04-May-2021, VACCINATION SITE PAIN (Very Sore Injection Site) and VACCINATION SITE SWELLING (Swollen Injection Site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itching Injection Site) and VACCINATION SITE ERYTHEMA (Red Injection Site (2" Circumference)) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No Relevant concomitant medications was reported. Treatment information was not provided.
Benign tremor in hands, Brain Fog, temporary memory loss, loss of motor function, difficulty maintaining balance, persistent headaches,  neck pain, random mysterious body aches that vary from time-to-time.  Most of the above issues have resolved within six weeks of the second injection other than the persistent headaches, brain fog, neck pain and various body aches.